Pharmacokinetics of dextromethorphan and dextrorphan in epileptic patients

Acta Neurologica Scandinavica

Volumn 93, Issue 2-3, 1996, Pages 94-98

  Kazis, A ^a   Kimiskidis, V ^a   Niopas, I ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

Anticonvulsants; Dextorphan; Dextrometorphan; Pharmacokinetics

Indexed keywords

CARBAMAZEPINE; DEXTROMETHORPHAN; DEXTRORPHAN; PHENYTOIN; VALPROIC ACID;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG METABOLISM; EPILEPSY; FEMALE; HUMAN; MALE; ORAL DRUG ADMINISTRATION; PHARMACOKINETICS;

EID: 0029936726     PISSN: 00016314     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0404.1996.tb00181.x     Document Type: Article

References (30)

1. APLAND JP, BRAITMAN DJ. Effects of non-opioid antitussives on epileptiform activity and NMDA responses in hippocampal and olfactory cortex slices. Brain Res 1990: 529: 277-285.
2. WONG BY, COULTER DA, CHOI DW, PRINCE DA. Dextrorphan and dextromethorphan, common antitussives, are antiepileptic and antagonize N-methyl-D-aspartate in brain slices. Neurosci Lett 1988: 85: 261-266.
3. CARPENTER CL, MARKS SS, WATSON DL, GREENBERG DA. Dextromethorphan and dextrorphan as calcium channel antagonists. Brain Res 1988: 439: 372-375.
4. NETZER R, PFLIMLIN P, TRUBE G. Dextromethorphan blocks N-methyl-D- aspartate-induced currents and voltage-operated inward currents in cultured cortical neurons. Eur J Pharmacol 1993: 238: 209-216.
5. TORTELLA FC, PELLICANO M, BOWERY NG. Dextromethorphan and neuromodulation: old drug coughs up new activities. Trends Pharmacol Sci 1989: 10: 501-507.
6. FISHER RS, CYSYK BJ, LESSER RP, PONTECORNO MJ, FERKANY JT, SCHWERDT PR. Dextromethorphan for treatment of complex partial seizures. Neurology 1990: 40: 547-549.
7. WOODWORTH JR, DENNIS SRK, MOORE L, ROTENBERG KS. The polymorphic metabolism of dextromethorphan. J Clin Pharmacol 1987: 27: 139-143.
8. CHEN ZR, SOMOGYI AA, BOCHNER F. Simultaneous determination of dextromethorphan and three metabolites in plasma and urine using high performance liquid chromatography with application to their disposition in man. Ther Drug Monit 1990: 12: 97-104.
9. ROWLAND M, TOZER TN. Clinical Pharmacokinetics: Concepts and Applications, 2nd Ed., Philadelphia: Lea & Febiger, 1989.
10. MILLER RP, GRAVES DA, MUIR KT. Dextromethorphan population kinetics. Clin Pharmacol Ther 1989: 45: 149.
11. BARNHART JW. Urinary excretion of dextromethorphan and three metabolites in dogs and humans. Toxicol Appl Pharmacol 1980: 55: 43-48.
12. PFAFF G, BRIEGEL P, LAMPBRECHT I. Inter-individual variation in the metabolism of dextromethorphan. Int J Pharmac 1983: 14: 173-189.
13. SILVASTI M, KARTTUNEN P, TUKIAINEN H, KOKKONEN P, HANNINEN U, NYKANEN S. Pharmacokinetics of dextromethorphan and dextrorphan: a single dose comparison of three preparations in human volunteers. Int J Clin Pharmacol Ther Toxicol 1987: 25: 493-497.
14. MORTIMER O, LINDSTROM B, LAURELL H, BERGMAN U, RANE A. Dextromethorphan: polymorphic serum pattern of the O-demethylated and didemethylated metabolites in man. Br J Clin Pharmacol 1989: 27: 223-227.
15. KRONBACH T, MATHYS D, GUT J, CATIN J, MEYER UA. High performance liquid chromatographic assays for bufuralol 1′-hydroxylase, debrisoquine 4-hydroxylase and dextromethorphan O-demethylase in microsomes and purified cytochrome P-450 isozymes of human liver. Analytical Biochem 1987: 162: 24-32.
16. EVANS DAP, MAHGOUB A, SLOAN TP, IDLE JR, SMITH RL. A family and population study of the genetic polymorphism of debrisoquine oxidation in a white European population. J Med Genet 1980: 17: 102-105.
17. GONZALEZ FJ, VILBOIS F, HARDWICK JP, et al. Human debrisoquine 4-hydroxylation (P450 IIDI):cDNA and deduced amino acid sequence and assignment of the CYP2D6 locus to chromosome 22. Genomics 1988: 2: 174-179.
18. BROLY F, LIBERSA C, LHERMITTE M, DUPUIS B. Inhibitory studies of mexiletine and dextromethorphan oxidation in human liver microsomes. Biochem Pharmacol 1990: 39: 1045-1053.
19. FAIGLE JW, FELDMANN KF. Carbamazepine-biotransformation. In: LEVY R, MATTSON R, MELDRUM B, PENRY JK, DREIFUSS FE, eds. Antiepileptic Drugs. New York: Raven Press, 1989: 491-504.
20. STEINBERG GK, KUNIS D, DELAPAZ R, POLJAK A. Neuroprotection following focal cerebral ischemia with the NMDA antagonist dextromethorphan, has a favourable dose response profile. Neurol Res 1993: 15: 174-180.
21. ZHANG Y, BRITTO MR, VALDERHANG KL, WEDLUND PJ, SMITH RA. Dextromethorphan: enhancing its systemic availability by way of low-dose quinidine-mediated inhibition of cytochrome 4502D6. Clin Pharmacol Ther 1992: 51: 647-655.
22. OTTON SV, DAFANG W, JOFFE RT, CHEUNG SW, SELLERS EM. Inhibition by fluoxetine of cytochrome P450 2D6 activity. Clin Pharmacol Ther 1993: 53: 401-409.
23. PRENDIVILLE S, GALE K. Anticonvulsant effect of fluoxetine on locally evoked limbic motor seizures in rats. Epilepsia 1993: 34(2): 381-384.
24. ARAM JA, ZEMAN S, MILLAR J, MARTIN D, LODGE D, TOMCZYK M. Neocortical epileptogenesis in vitro: studies with N-methyl-D-aspartate, phencyclidine, sigma and dextromethorphan receptor ligands. J Pharmacol Exp Ther 1989: 248: 320-328.
25. STEINBERG GK, BELL T. Clinical dose-escalation safety study of the NMDA antagonist dextromethorphan in neurosurgical patients. Stroke 1991: 22: 141.
26. DZIKI M, HONACK D, LOSHER W. Kindled rats are more sensitive than non-kindled rats to the behavioural effects of combined treatment with MK-801 and valproate. Eur J Pharmacol 1992: 22: 273-278.
27. TRUBE G, NETZER R. Dextromethorphan: cellular effects reducing neuronal hyperexcitability. Epilepsia 1994: 35(Suppl 5): S62-S67.
28. STEINBERG GK, KUNIS D, SALEH J, DELAPAZ R. Protection after transient focal cerebral ischemia by the N-methyl-D-Aspartate antagonist is dependent upon plasma and brain levels. J Cereb Blood Flow Metab 1991: 11: 1015-1024.
29. WILLS RJ, MARTIN KS. Dextromethorphan dextrorphan disposition in rat plasma and brain. Pharm Res 1988: 5(Suppl): S193.
30. JACQZ-AIRGRAIN E, FUNCK-BRENTANO C, CRESTEIL T. CYP2D6- and CYP3A4-dependent metabolism of dextromethorphan in humans. Pharmacogenetics 1993: 3: 197-204.